These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21950596)

  • 21. [Value and applications of pharmacogenetics in oncology and hematology].
    Albin N; Massade L; Gouyette A
    Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent developments of pharmacogenomics in the treatment of colorectal cancers].
    Astier A
    Ann Pharm Fr; 2010 Jul; 68(4):233-53. PubMed ID: 20637356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspective on the application of pharmacogenomics in the treatment of cancer.
    Wolf R
    Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current status and problems of tailor-made medicine in anticancer therapy].
    Miya T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):515-9. PubMed ID: 17431334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenetics in oncology].
    Morán González D; Jiménez Cabrera S; Domínguez-Gil Hurlé A
    Med Clin (Barc); 2008 Jul; 131(5):184-95. PubMed ID: 18674490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
    Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
    Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
    Tran HT; Liu Y; Zurita AJ; Lin Y; Baker-Neblett KL; Martin AM; Figlin RA; Hutson TE; Sternberg CN; Amado RG; Pandite LN; Heymach JV
    Lancet Oncol; 2012 Aug; 13(8):827-37. PubMed ID: 22759480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics and breast cancer management: current status and perspectives.
    Ciccolini J; Fanciullino R; Serdjebi C; Milano G
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):719-29. PubMed ID: 25690018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of clinically relevant markers and therapeutic targets.
    Nicolette CA; Miller GA
    Drug Discov Today; 2003 Jan; 8(1):31-8. PubMed ID: 12546989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology.
    McDermott U; Settleman J
    J Clin Oncol; 2009 Nov; 27(33):5650-9. PubMed ID: 19858389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status of Immune Oncology: Challenges and Opportunities.
    Cesano A; Marincola FM; Thurin M
    Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.
    Jones RT; Felsenstein KM; Theodorescu D
    Urol Clin North Am; 2016 Feb; 43(1):77-86. PubMed ID: 26614030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomic progress in individualized dosing of key drugs for cancer patients.
    Walko CM; McLeod H
    Nat Clin Pract Oncol; 2009 Mar; 6(3):153-62. PubMed ID: 19174777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
    Shai RM; Reichardt JK; Chen TC
    Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.